Skip to content

Study · Measured the body's own peptide · 2010

1 result

Resistance training with vascular occlusion in inclusion body myositis: a case study.

Gualano B, Neves M Jr, Lima FR, Pinto AL, Laurentino G, Borges C, Baptista L, Artioli GG, Aoki MS, Moriscot A, Lancha AH Jr, Bonfá E, Ugrinowitsch C

Medicine and science in sports and exercise1 Feb 2010Cited by 72 (Europe PMC)

PMID19927034 (opens in a new tab)DOI10.1249/mss.0b013e3181b18fb8 (opens in a new tab)PepBankPUB-19927034
Source linkPubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelCase report or seriesMechanism

    In a man with inclusion body myositis, muscle MGF mRNA expression increased 3.97-fold after 12 weeks of resistance training with vascular occlusion.

    In plain wordsIn one man with inclusion body myositis, the body's own MGF level in muscle rose after 12 weeks of occlusion training.

    Peptide
    MGF / PEG-MGF
    Outcome
    IncreaseMGF mRNA expression after 12 weeks of resistance training with vascular occlusion
    Study

    n = 1

    Comparator
    Baseline
    Outcome group
    Muscle injury and repair · Musculoskeletal

    Measurements

    MGF mRNA expression
    3.97 fold
    after 12-wk training

    Source sentences

    Summary
    mRNA expression of mechanogrowth factor increased 3.97-fold, whereas that of atrogin-1 decreased 0.62-fold.
    1 context sentence
    Summary · context
    A 65-yr-old man with IBM resistant to all proposed treatments underwent resistance training with vascular occlusion for 12 wk.

    This result measures the body's own MGF / PEG-MGF. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.